Clinical trial registry record

Aging, Geriatric Syndromes and Clonal Hematopoiesis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated July 13, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT02604563
Last registry update
July 13, 2026
Status
Recruiting
Phase
Phase not reported
Sponsor
Washington University School of Medicine
Enrollment
2000
Countries
United States
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
2000
Population
ALL · 50 Years
Duration
2016-03-10 to 2030-04-30
Intervention
Cognitive Assessment; Activities of Daily Living Questionnaire; Instrumental Activities of Daily Living, subscale of the OARS; Karnofsky Self-reported Performance Rating Scale; Number of Falls; Physical Health Section, subscale of the OARS; MOS Social Activity Survey; Unintentional Weight Loss; Peripheral Blood Draw; Buccal Swab; Heart Health and Smoking History from BRFSS questionnaire; Gait Speed; Grip Strength; Height and Weight measurements; Blood pressure measurement; Optional bone marrow biopsy; Blood draw for trauma measurements; Femur head donation; Knee bone fragments; Bone marrow aspirate
Comparator
Not reported
Outcomes measured
Background mutation rate in hematopoietic stem cells from older adults regardless of a prior cancer diagnosis as measur…; Presence or absence of geriatric syndromes as measured by hematopoietic stem cell mutations — Estimated to be 10 years; Determine the natural history of mutations in older adults with clonal hematopoiesis as measured by risk to develop blo…; Presence or absence of cardiovascular disease as measured by hematopoietic stem call mutations — Estimated to be 10 yea…; Determine whether expansion of clonal hematopoiesis (CH) occurs following acute trauma — Estimated to be 10 years
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 80% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Clonal haematopoiesis · 80%Title contains controlled term: clonal hematopoiesis. Title supplies longevity context: aging, geriatric. Study type is explicitly identified as OBSERVATIONAL.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.